Skip to content

Clinical trials

Withdrawn Hematologic Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Neoplasms Status: Withdrawn Clear all

71 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20061
20071
20081
20101
20115
20123
20134
20145
20152
20164
20173
20183
20192
202010
202110
20227
20231
20243
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn71

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
City of Hope Medical Center5
M.D. Anderson Cancer Center5
National Cancer Institute (NCI)4
Mayo Clinic3
Tarix Pharmaceuticals3
Baptist Health South Florida2
Baylor College of Medicine2
Bellicum Pharmaceuticals2
Imperial College London2
Kiromic BioPharma Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Neoplasms71
Lymphoma9
Leukemia8
Multiple Myeloma8
Precursor Cell Lymphoblastic Leukemia-Lymphoma7
Leukemia, Lymphocytic, Chronic, B-Cell6
Leukemia, Myelogenous, Chronic, BCR-ABL Positive6
Leukemia, Myeloid, Acute6
Myelodysplastic Syndromes6
Neoplasms6

Trials

Showing 1 to 25 of 71. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.